EyePoint

EYPTNasdaq United States Industrials Biotechnology: Laboratory Analytical Instruments

Market cap

$331.917 M

$3.85 -3.51%

Close of 18 Sept 2026

Revenue

$31.4M

#2871 by revenue

Earnings

-$232.0M

Loss-making

Shares outstanding

86,212,138

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →

#10Cytek BiosciencesCTKB$688.9M
#11Pacific Biosciences Of CaliforniaPACB$425.8M
#12EyePointEYPT$331.9M
#13Standard BiotoolsLAB$302.2M
#14QuanterixQTRX$145.2M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of EyePoint, worth $52.3K. Grants and option exercises are excluded.

Karen L. Zaderej$52.3K
10,600 shares at $4.93 on 18 Aug 2026 · filed 18 Aug 2026

What if EyePoint were worth as much as…

Open the what-if tool →

Gold $30.4T

$352,473.09

Per share 91,551× higher

Bitcoin $1.64T

$18,976.77

Per share 4,929× higher

Nvidia $5.36T

$62,134.02

Per share 16,139× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for EyePoint are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.